Multi-organ impairment and Long COVID: a 1-year prospective, longitudinal cohort study
Andrea Dennis, Amitava Banerjee(University College London), Sofia Mouchti(Oxfam), Dan Wootton(University of Liverpool), Melissa Heightman(University College London Hospitals NHS Foundation Trust), Emily Attree, Michael G. Crooks(Hull York Medical School), Matt Kelly(CRUK/MRC Oxford Institute for Radiation Oncology), Lyth Hishmeh(SOAS University of London), Adriana Roca‐Fernández(National Health Service), Rajarshi Banerjee(John Radcliffe Hospital), Matthew D. Robson(John Radcliffe Hospital), Michele Pansini(John Radcliffe Hospital), Mark Gabbay(University of Liverpool), Helena Thomaides‐Brears, Daniel J. Cuthbertson(University of Liverpool), Nicole Eichert(Oxfam)
Cited by 14
Related Papers
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
|JAMA|2017|2.4k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
|The Lancet Global Health|2020|1.2k
Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis
|JACC. Cardiovascular imaging|2013|664